Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to <i>Flt3-</i>ITD mutations.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27879203.
- Also identified by DOI 10.7554/eLife.18882 and PMC identifier 5153248.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The <i>FLT3</i> Internal Tandem Duplication (<i>FLT3<sup>ITD</sup></i>) mutation is common in adult acute myeloid leukemia (AML) but rare in early childhood AML. It is not clear why this difference occurs. Here we show that <i>Flt3<sup>ITD</sup></i> and cooperating <i>Flt3<sup>ITD</sup>/Runx1</i> mutations cause hematopoietic stem cell depletion and myeloid progenitor expansion during adult but not fetal stages of murine development. In adult progenitors, FLT3<sup>ITD</sup> simultaneously induces self-renewal and myeloid commitment programs via STAT5-dependent and STAT5-independent mechanisms, respectively. While FLT3<sup>ITD</sup> can activate STAT5 signal transduction prior to birth, this signaling does not alter gene expression until hematopoietic progenitors transition from fetal to adult transcriptional states. Cooperative interactions between <i>Flt3<sup>ITD</sup></i> and <i>Runx1</i> mutations are also blunted in fetal/neonatal progenitors. Fetal/neonatal progenitors may therefore be protected from leukemic transformation because they are not competent to express FLT3<sup>ITD</sup> target genes. Changes in the transcriptional states of developing hematopoietic progenitors may generally shape the mutation spectra of human leukemias.
Medical subject headings
- Core Binding Factor Alpha 2 Subunit
- Fetal Stem Cells
- Gene Expression Regulation, Leukemic
- Hematopoietic Stem Cells
- Leukemia, Myeloid, Acute
- fms-Like Tyrosine Kinase 3